Atrial fibrillation associated with ibrutinib in Waldenström macroglobulinemia

Am J Hematol. 2016 Jun;91(6):E312-3. doi: 10.1002/ajh.24366. Epub 2016 Apr 28.

Authors

Joshua N Gustine¹, Kirsten Meid¹, Toni E Dubeau¹, Steven P Treon^{1

2}, Jorge J Castillo^{1

2}

Affiliations

¹ Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts.

PMID: 26994323
DOI: 10.1002/ajh.24366

No abstract available

Publication types

Clinical Trial
Letter
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adenine / analogs & derivatives
Adult
Aged
Aged, 80 and over
Atrial Fibrillation / chemically induced*
Atrial Fibrillation / epidemiology*
Female
Humans
Male
Middle Aged
Piperidines
Pyrazoles / administration & dosage
Pyrazoles / adverse effects*
Pyrimidines / administration & dosage
Pyrimidines / adverse effects*
Risk Factors
Time Factors
Waldenstrom Macroglobulinemia / drug therapy*
Waldenstrom Macroglobulinemia / epidemiology*

Substances

Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine